Miracle Recovery: Newborn Survives Severe Blood Disorder After Emergency Treatment
Miracle Recovery: Newborn Survives Severe Blood Disorder After Emergency Treatment
Miracle Recovery: Newborn Survives Severe Blood Disorder After Emergency Treatment
A newborn boy in Ho Chi Minh City survived a rare and severe blood condition after emergency treatment at Children's Hospital 2. The 30-hour-old infant suffered from extreme jaundice caused by a combination of ABO and Rh blood group incompatibilities. Doctors acted quickly to stabilise his condition using advanced medical procedures.
The baby's skin turned yellow within the first day of life due to immune haemolysis—a reaction triggered by mismatched blood types between mother and child. His mother, who had Rh-negative blood, had not received preventive Anti-D treatment during pregnancy. The jaundice soon spread to his palms and soles, while his bilirubin levels soared past the critical threshold.
Medical staff at Children's Hospital 2 performed a double-volume exchange transfusion, combined with immunoglobulin therapy and intensive phototherapy. After seven days of treatment, the infant's neurological condition stabilised, and his critical indicators improved enough for discharge. Doctors have stressed the importance of early detection in such cases. They advise parents to seek immediate help if a newborn develops jaundice within 24 hours of birth, particularly if it reaches the legs, palms, or soles. Other warning signs include lethargy, poor feeding, or unusual stiffness. Experts also recommend that pregnant women undergo blood group and Rh factor testing early, with Rh-negative mothers receiving preventive Anti-D injections under specialist supervision. While modern neonatal care can treat many life-threatening conditions, proper screening and timely intervention remain vital for protecting newborns in their first hours.
The infant's successful recovery highlights the effectiveness of advanced medical treatments for severe blood incompatibilities. However, doctors continue to emphasise that early testing and preventive care during pregnancy are key to reducing risks. Without proper monitoring, such conditions can escalate rapidly in newborns.